[ RECIPIENT ENTITY RECORD ]

Cerevel Therapeutics Inc.

VERIFIED NODE ID: 002037 · cerevel-therapeutics-inc
R TARGET NODE — CAPITAL RECIPIENT
Cerevel Therapeutics Inc.
Company United States
Recipient Type
Company
Primary Jurisdiction
United States
Registration Status
ACTIVE
Entity Intelligence [ R ]
Legal Name Cerevel Therapeutics Inc.
Entity Type Company
Jurisdiction United States
Recipient Intelligence Summary

Cerevel Therapeutics is a biopharmaceutical company that leverages its deep understanding of neuroscience to develop transformative therapies for brain disorders like Parkinson’s. Based in Massachusetts, the firm has a diverse pipeline of neurological drug candidates. It was a major recipient of institutional healthcare capital through its strategic merger.

Capital Influx Log (Transactions)
Date Type Amount
23 May 2026 EQUITY $8.7B